These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24614272)

  • 21. Dementia registries around the globe and their applications: A systematic review.
    Krysinska K; Sachdev PS; Breitner J; Kivipelto M; Kukull W; Brodaty H
    Alzheimers Dement; 2017 Sep; 13(9):1031-1047. PubMed ID: 28576507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
    Kennedy RE; Cutter GR; Wang G; Schneider LS
    Am J Geriatr Psychiatry; 2017 Oct; 25(10):1150-1159. PubMed ID: 28554539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruiting to preclinical Alzheimer's disease clinical trials through registries.
    Grill JD
    Alzheimers Dement (N Y); 2017 Jun; 3(2):205-212. PubMed ID: 28439532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes toward Potential Participant Registries.
    Grill JD; Holbrook A; Pierce A; Hoang D; Gillen DL
    J Alzheimers Dis; 2017; 56(3):939-946. PubMed ID: 28106553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status Disclosure.
    Ott BR; Pelosi MA; Tremont G; Snyder PJ
    Alzheimers Dement (N Y); 2016 Jan; 2(1):23-29. PubMed ID: 27019867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing ethnic minority participation in Alzheimer disease research.
    Olin JT; Dagerman KS; Fox LS; Bowers B; Schneider LS
    Alzheimer Dis Assoc Disord; 2002; 16 Suppl 2():S82-5. PubMed ID: 12351920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community engagement in diverse populations for Alzheimer disease prevention trials.
    Romero HR; Welsh-Bohmer KA; Gwyther LP; Edmonds HL; Plassman BL; Germain CM; McCart M; Hayden KM; Pieper C; Roses AD
    Alzheimer Dis Assoc Disord; 2014; 28(3):269-74. PubMed ID: 24614272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
    Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
    Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).
    Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.
    Aggarwal R; Sidnam-Mauch E; Neffa-Creech D; Plant A; Williams E; Shami E; Menon U; George S; Langbaum JB
    J Prev Alzheimers Dis; 2023; 10(4):857-864. PubMed ID: 37874108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies.
    Cocroft S; Welsh-Bohmer KA; Plassman BL; Chanti-Ketterl M; Edmonds H; Gwyther L; McCart M; MacDonald H; Potter G; Burke JR
    Alzheimers Dement; 2020 Aug; 16(8):1107-1114. PubMed ID: 32543781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research.
    Esiaka D; Yarborough CC; Fausto BA; Gluck MA
    Community Health Equity Res Policy; 2024 Jul; 44(4):419-428. PubMed ID: 36120808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using genetics to enable studies on the prevention of Alzheimer's disease.
    Crenshaw DG; Gottschalk WK; Lutz MW; Grossman I; Saunders AM; Burke JR; Welsh-Bohmer KA; Brannan SK; Burns DK; Roses AD
    Clin Pharmacol Ther; 2013 Feb; 93(2):177-85. PubMed ID: 23249780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
    Reiman EM; Langbaum JB; Fleisher AS; Caselli RJ; Chen K; Ayutyanont N; Quiroz YT; Kosik KS; Lopera F; Tariot PN
    J Alzheimers Dis; 2011; 26 Suppl 3(Suppl 3):321-9. PubMed ID: 21971471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.
    Bateman RJ; Aisen PS; De Strooper B; Fox NC; Lemere CA; Ringman JM; Salloway S; Sperling RA; Windisch M; Xiong C
    Alzheimers Res Ther; 2011 Jan; 3(1):1. PubMed ID: 21211070
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.